4//SEC Filing
Broadfoot Jill Marie 4
Accession 0001209191-23-007364
CIK 0001339970other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 7:00 PM ET
Size
9.3 KB
Accession
0001209191-23-007364
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
Broadfoot Jill Marie
Chief Financial Officer
Transactions
- Exercise/Conversion
Restricted Stock Unit
2023-02-03−3,750→ 11,250 total→ Common Stock (3,750 underlying) - Exercise/Conversion
Common stock
2023-02-03+3,750→ 17,026 total - Sale
Common stock
2023-02-06$2.36/sh−1,566$3,696→ 15,460 total
Footnotes (5)
- [F1]Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 3, 2022.
- [F2]Restricted stock units convert into common stock on a one-for-one basis.
- [F3]Includes 986 shares acquired under that Company's 2015 Employee Stock Purchase Plan on November 15, 2022.
- [F4]Sale made by the Reporting Person to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on February 3, 2022.
- [F5]The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
Documents
Issuer
aTYR PHARMA INC
CIK 0001339970
Entity typeother
Related Parties
1- filerCIK 0001305178
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 7:00 PM ET
- Size
- 9.3 KB